tirzepatide court ruling today Lilly Takes Four Compounders to for Allegedly Producing Knockoff GLP-1 Saga Continues: FDA Ends

Description

Increasing your water intake, eating more vegetables, and exercising are a few ways to get your bowels moving regularly

If youre on self-injectable medications, ensure proper storage and administration techniques

Introduction Recently, a consensus on a new nomenclature has been proposed, with metabolic dysfunction-associated steatotic liver disease (MASLD) replacing nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatohepatitis (MASH) replacing nonalcoholic steatohepatitis (NASH)

Reference List BuzzRx

Immediate medical attention is required if thirst is accompanied by any of the following: Severe or persistent vomiting or diarrhoea leading to inability to maintain hydration Signs of dehydration such as dizziness, reduced urine output, dark-coloured urine, or dry mucous membranes Symptoms suggestive of hypoglycaemia (blood glucose below 4 mmol/L) that do not resolve with standard treatment Severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists Symptoms of DKA, including rapid breathing, fruity breath odour, confusion, or loss of consciousness If pancreatitis is suspected (severe, persistent abdominal pain, possibly radiating to the back), stop taking semaglutide and seek urgent medical assessment